Vogenx, Inc. (VOGX) stock
VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$12.34−1.14 (-8.46%)
Close on Nov 18, 2026Market cap $183.31MP/E –Yield –
Vogenx net income
Net income is the profit left for shareholders after every expense, interest and tax.
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$384.43K | – |
| Q1 FY2026 | Mar 31, 2026 | -$475.45K | – |
| Q2 FY2025 | Jun 30, 2025 | -$294.80K | – |
| Q1 FY2025 | Mar 31, 2025 | -$356.62K | – |
See a number that looks wrong?